First Republic Investment Management, Inc. Intra Cellular Therapies, Inc. Put Options Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
383Shares Held
77.8MCall Options Held
1.7MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA9.23MShares$721 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.08MShares$631 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$301 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$220 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$193 Million2.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.38B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...